Please login to the form below

Bioverativ

This page shows the latest Bioverativ news and features for those working in and with pharma, biotech and healthcare.

Sanofi exits R&D pact with Alnylam on rare disease

Bioverativ an Ablynx last year. ... Haemophilia and other rare blood diseases have become key therapeutic targets for Sanofi in the wake of its acquisition of Bioverativ – which gave it long-acting clotting factor therapies Eloctate and

Latest news

Sanofi extends growth spurt thanks to Genzyme, Dupixent

While growth for haemophilia treatments Eloctate and Alprolix – acquired as part of Sanofi’s $11.9bn acquisition of Bioverativ last year – remained fairly sluggish, the quarter was marked first sales contribution
Sanofi gets US okay for $270,000 blood disorder drug Cablivi

It is the first US drug approval for Sanofi’s rare blood disorders franchise, which also includes haemophilia drugs acquired along with Biogen spin-off Bioverativ in 2018.
AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

The deal represents a major expansion for Sobi, which is currently focused on rare diseases and haemophilia in Europe (the latter through a licensing deal with Bioverativ), with limited penetration into
Sanofi gets EU OK for Ablynx flagship drug Cablivi

of Bioverativ earlier this year which added two marketed haemophilia drugs as well as a pipeline of blood disorder products including genome editing drugs and gene therapies.
Dupixent bounce-back helps stem diabetes declines at Sanofi

A bright point was the rare blood disorder business bolted on with the $11.6bn acquisition of Bioverativ, up 15.5% on a pro forma basis to 257m, and Sanofi is

More from news
Approximately 3 fully matching, plus 16 partially matching documents found.

Latest Intelligence

Deal Watch January 2018

Biogen's spin-out, Bioverativ, had not even got past its first anniversary as a Nasdaq-listed company before being snapped up by Sanofi for $11.6bn (although this is not ... only with its rare disease focus but also enhances its portfolio of products for

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Industry appointments

Rogerio Vivaldi leaves Bioverativ buyout to head up Sigilon. US-based biotech Sigilon aiming to deliver stem cell therapies for diabetes is getting a new leader. ... The firm has managed to poach Bioverativ’s senior executive Rogerio Vivaldi (pictured
Voyager Therapeutics appoints Matthew Ottmer as chief operating officer

the chief executive officer and president of Syntonix Pharmaceuticals - a wholly owned subsidiary of Biogen, now Bioverativ - and vice president of global operations.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Senior Medical Writer: Competitive salary and benefits

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Director – Healthcare PR: Salary TBC

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

PR Associate Director – Consumer Health & Beauty: Salary TBC

Account Director, Medical Education: Salary TBC

Senior Medical Writer: Salary TBC

Editor – Medical Education Agency – Bucks: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...